Concure Oncology/Breast Microseed Inc. announced the launch of its one-time, one-hour radiation treatment option for early-stage breast cancer.

Using a new imaging agent that binds to tau protein and makes it visible in positron emission tomography (PET) scans, scientists at Washington University School of Medicine in St. Louis have shown that measures of tau are better markers of the cognitive decline characteristic of Alzheimer’s than measures of amyloid beta seen in PET scans.

Winthrop-University Hospital, Mineola, N.Y., recently added a universal viewer to its Carestream Vue for Clinical Collaboration Platform.

May 11, 2016 — ITM (Isotopen Technologien München AG), a specialized radiopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) , has adopted a positive opinion on the Marketing Authorization Application (MAA) for EndolucinBeta. The radiopharmaceutical is a product of ITM´s subsidiary ITG Isotope Technologies Garching GmbH. CHMP is part of the European Medicines Agency (EMA).

May 11, 2016 — aycan and business partner medQ, each celebrate 20-year anniversaries this month. Their partnership led to the creation of their joint solution, aycan workflow, a fully integrated radiology information system (RIS)/picture archiving and communication system (PACS) solution that provides a turnkey end-to-end digital imaging and patient management system.

Children in Tanzania with anorectal malformations received life-changing corrective surgeries with the help of Toshiba’s ultrasound during a recent mission conducted by Cincinnati Children’s Hospital Medical Center.

Varian Medical Systems delivered the cyclotron for the new multi-room HollandPTC in Delft, the Netherlands, which will be equipped with the Varian ProBeam proton therapy system.

Hippocrates viewed the patient as a whole. Today physicians tend to see the patient as a collection of parts — cardiologists hearts; orthopedists joints. http://www.itnonline.com/content/impracticality-truly-universal-viewer-enterprise-imaging

Imricor Medical Systems announced enrollment of the first patients in a clinical study to evaluate the Vision-MR Ablation Catheter for the treatment of atrial flutter under real-time magnetic resonance imaging (MRI) guidance.

Subscribe Now